Alemtuzumab Pharmacokinetics in Hematopoietic Stem Cell Transplants for Nonmalignant Genetic Diseases

Biol Blood Marrow Transplant. 2015 Jul;21(7):1337. doi: 10.1016/j.bbmt.2015.04.013. Epub 2015 May 9.

Authors

Akshat Jain¹, Indira Sahdev²

Affiliations

¹ Steven and Alexandra Cohen Children's Medical Center of New York, New York, New York. Electronic address: dostakshat@gmail.com.
² Steven and Alexandra Cohen Children's Medical Center of New York, New York, New York.

PMID: 25963918
DOI: 10.1016/j.bbmt.2015.04.013

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Marrow Transplantation*
Female
Genetic Diseases, Inborn / mortality*
Genetic Diseases, Inborn / therapy*
Graft Survival*
Humans
Male
Myeloablative Agonists / administration & dosage*
Transplantation Conditioning*

Substances

Myeloablative Agonists